The Open

The Long Desk

The Close · The Open · The Long Desk · Archive · Research
Fri, 21 Aug 2026
2000 companies · 2294 sector slots · 12 sectors · long-term lens

Trend Spotlight

Fed Chair Powell's dovish Jackson Hole pivot pushes September rate-cut odds above 90%, a global liquidity tailwind arriving just as Nifty snapped a seven-session losing streak.

Powell told Jackson Hole the Fed's 'shifting balance of risks' may warrant loosening policy, and markets read it as a green light for a 25bp September cut, with CME-tracked odds jumping above 90% and consensus now pricing up to 100bp of 2026 easing toward a 3.00% funds rate by year-end. US equities rallied on the news (S&P 500 +0.4%, Dow +1.0%) and GIFT Nifty points to a positive Aug 22 open. For a long-term Indian-equity holder this matters beyond one session — a genuinely easier Fed widens the RBI's own room to ease further, having just held its repo rate at 5.25% in its August review — though the rupee still sits under pressure from a second straight weekly rise in Brent crude near $94, a reminder that one macro tailwind doesn't offset another headwind.

Day ahead

GIFT Nifty points to a modestly positive Aug 22 open, with Brent near $94 the one headwind against an otherwise constructive overnight setup.

GIFT Nifty traded around 24,329 (+0.18%), tracking Friday's rebound that snapped Nifty's seven-session losing streak, with Wall Street closing broadly higher overnight (S&P 500 +0.4% to 7,674.37, Dow +1.0%, Nasdaq +0.4%) on the dovish Powell read. Brent crude held near $93.82/bbl, a second straight weekly gain on the unresolved US-Iran standoff over the Strait of Hormuz — a net negative for India's import bill and the rupee. India's own Q1 FY27 GDP print is due Aug 31, with forecasts diverging widely (SBI Research at 8.0% vs Bank of Baroda/ICRA at 7.0-7.2%), against a backdrop of the RBI holding its repo rate at 5.25% in its August review while flagging inflation peaking near 5.9% in Q3.

Reporting today

No tracked name reports today.

Coming up

Source: NSE event calendar, filtered to the 2000 tracked names.

Market Overview

IndexClosePoints ChangeP/EP/B
Nifty 50 24,252.00 ▲ +20.15 ▲ +0.08% 20.50 2.94
Nifty Next 50 73,992.10 ▼ -202.05 ▼ -0.27% 19.56 3.32
Nifty 500 23,530.30 ▲ +17.35 ▲ +0.07% 22.86 3.29
Nifty Bank 57,761.95 ▲ +266.05 ▲ +0.46% 13.67 1.73
NIFTY Midcap 100 63,735.75 ▲ +64.20 ▲ +0.10% 30.72 4.44
▲ 1300 advancing ■ 53 unchanged ▼ 1271 declining of 2624 equities, vs the 2026-08-20 close
Cash market, ₹ crore
FII / FPI net
▼ -542.71
bought 12,561 · sold 13,104
DII net
▲ +2,124.14
bought 15,259 · sold 13,135

Source: NSE ind_close_all_20260821 (levels, index P/E and P/B) and the full-market bhavcopy (breadth).

Since We Flagged

The desk's track record — the FIRST call made on each standing name, against its call today. Entry price is the close on the day of that first call, read from the cached bhavcopy for that date. "Unchanged" means the original call still stands.

CompanyFirst flaggedVerdict then Verdict nowAt flagNow Move
Goodluck India LtdGOODLUCK Tue, 18 Aug 2026 BUY unchanged ₹1,330.00 ₹490.90 ▼ -63.1%
Kronox Lab Sciences LtdKRONOX Tue, 18 Aug 2026 HOLD unchanged ₹151.70 ₹215.18 ▲ +41.8%
Welspun Corp LtdWELCORP Wed, 5 Aug 2026 BUY unchanged ₹1,788.10 ₹2,311.90 ▲ +29.3%
Kwality Walls India LtdKWIL Tue, 18 Aug 2026 BUY unchanged ₹38.10 ₹48.35 ▲ +26.9%
Swiss Military Consumer Goods LtdSWISSMLTRY Tue, 18 Aug 2026 HOLD unchanged ₹14.01 ₹17.48 ▲ +24.8%
Bajaj Hindusthan Sugar LtdBAJAJHIND Tue, 18 Aug 2026 AVOID unchanged ₹18.60 ₹23.13 ▲ +24.4%
Kothari Sugars & Chemicals LtdKOTARISUG Tue, 18 Aug 2026 AVOID unchanged ₹26.89 ₹33.29 ▲ +23.8%
Allcargo Logistics LtdALLCARGO Tue, 18 Aug 2026 AVOID unchanged ₹9.97 ₹12.17 ▲ +22.1%
Birla Precision Technologies LtdBIRLAPREC Tue, 18 Aug 2026 HOLD unchanged ₹36.49 ₹44.40 ▲ +21.7%
Mawana Sugars LtdMAWANASUG Tue, 18 Aug 2026 AVOID unchanged ₹125.74 ₹152.54 ▲ +21.3%
Zaggle Prepaid Ocean Services LtdZAGGLE Tue, 18 Aug 2026 HOLD unchanged ₹165.88 ₹200.12 ▲ +20.6%
Dwarikesh Sugar Industries LtdDWARKESH Tue, 18 Aug 2026 HOLD unchanged ₹44.64 ₹53.63 ▲ +20.1%

Source: data/state.json (call memory) × data/prices/<date>.json.

Top Stories

Jana SFB's more recent Q4 FY26 numbers complicate the Q3 profit-collapse narrative, without resolving it Banks

JSFB's Q4 FY26 investor presentation shows PAT of Rs 140 crore (in line with guidance), 23% YoY growth in assets and deposits, GNPA down to 2.3% and declining net credit cost, with the bank shifting its mix away from microfinance (now ~27% of the book, from 40% in March 2024). That's in tension with the Q3 FY26 collapse (-90.6% YoY profit, 16.6% JLG bad-loan ratio) underlying the open ledger claim, though full-year FY26 profit is still down 34.9% YoY and the sourcing is second-hand rather than a fetched transcript — this nudges, but doesn't resolve, the deterioration thesis.

JSFB

Lupin's US business grew fast last quarter, but management still guides the run-rate down as generic competition bites Pharmaceuticals

Coverage of Lupin's most recent US quarter shows sales up 47% YoY on continued Tolvaptan exclusivity and new launches, yet management holds its guide toward $250-280M in quarterly US sales (down from Q1's $366M) as Apotex, Teva and a possible fourth generic entrant erode pricing, with recovery still pointed at FY28. Two evidence sources gave the growth figure as '$315M, Q2 FY27' and '$366M, Q1' for what reads like the same underlying trend — a discrepancy worth a primary-source check before it drives a score. Either way, this reinforces rather than resolves the open trough claim.

LUPIN

Infosys formalizes its second FY27 guidance cut; HCLTech's guidance stays exactly where it was Information Technology

Infosys trimmed FY27 constant-currency revenue guidance to 1.5-3.0% (from 1.5-3.5%) at its Q1 results, citing softer volumes, a one-time client contract termination and macro uncertainty, even as deal TCV came in strong ($3.6bn, 61% net new). HCLTech's own 1.0-4.0% FY27 guide, set at its Q4 FY26 results, has seen no revision either way. Both continue, rather than change, the pattern the open claim already tracks: strong order books across large-cap IT, but nobody raising.

INFY · HCLTECH

The NCLT case against Max Healthcare's newly acquired Kalinga Hospital drags into a third adjournment Healthcare & Hospitals

BRS Capital Two's oppression/mismanagement petition against Kalinga Hospital — the Bhubaneswar hospital Max Healthcare bought a 58.28% controlling stake in for ~Rs 298 crore in May 2026 — was adjourned again on Aug 19, to Sept 8, with BRS Capital's own counsel seeking the delay this time. An interlocutory petition inside the case is specifically trying to block a postal ballot that would raise the hospital's borrowing limits, so the unresolved dispute could constrain KHL's own ability to fund its expansion while it drags on.

MAXHEALTH

Sector Scorecard

Entry score is 40% cheap-vs-history + 25% quality trend + 20% news catalyst + 15% technicals, for the 5 sectors with a researched catalyst. The other 7 show : no catalyst was researched for them, so their score renormalises over the remaining three inputs rather than assuming a neutral headline. ≥62 accumulate · 45–61 watch · <45 avoid.

SectorStanceEntryCheap QualityTechNews IndexIdx P/EB/W/H/A
Information Technology 10 scanned · 4 researched ACCUMULATE 64.5 61.0 93.2 45.3 +0 ▼ -0.46% 19.5 2/4/4/0
Banks 40 scanned · 11 researched AVOID 40.8 20.1 52.3 64.0 +0 ▲ +0.46% 13.7 10/1/24/5
Pharmaceuticals 20 scanned · 7 researched AVOID 41.9 7.9 75.2 66.7 +0 ▼ -0.21% 40.8 1/9/9/1
Automobiles 15 scanned · 5 researched AVOID 39.5 7.0 76.0 65.4 ▼ -0.60% 33.8 2/6/5/2
FMCG 15 scanned · 3 researched ACCUMULATE 84.7 94.3 94.7 42.2 ▼ -0.74% 33.0 1/7/7/0
Metals & Mining 15 scanned · 3 researched WATCH 45.4 12.9 77.1 73.4 +0 ▲ +0.86% 16.0 4/3/6/2
Realty 10 scanned · 2 researched WATCH 52.0 39.1 60.4 75.2 +0 ▲ +0.40% 38.7 1/2/3/4
Energy & Power 40 scanned · 1 researched ACCUMULATE 62.5 60.0 69.2 57.7 ▲ +0.26% 14.8 7/4/15/14
Financial Services 94 scanned · 5 ranked elsewhere · 1 researched WATCH 47.8 58.9 23.1 59.1 ▲ +0.22% 16.1 9/1/63/21
Healthcare & Hospitals 20 scanned · 16 ranked elsewhere · 8 researched AVOID 43.3 13.4 77.9 65.3 ▼ -0.25% 43.0 1/7/11/1
Hospitality & Tourism 15 scanned · 2 researched WATCH 60.2 52.7 71.3 61.6 ▼ -0.53% 90.3 4/4/3/4
Diversified & Other 2000 scanned · 273 ranked elsewhere · 41 researched WATCH 55.4 50.0 62.2 58.6 274/237/881/608

Source: data/verdicts.json × NSE sector index closes.

Stocks to Watch

New calls first, then the highest long-term composites. Each shows the figures that selected it — open the desk for the full six-lens panel.

new call this session
P/E in the 0th percentile of its own 3-year range · Piotroski 7/9 · -34.3% off its 52-week high
Composite 84.0 P/E 28.1 ROCE 46.1% Piotroski 7/9
new call this session
P/E in the 10th percentile of its own 3-year range · ROCE 21.2% (up 4.2pt over 5y)
Composite 82.2 P/E 45.31 ROCE 21.2% Piotroski 6/8
new call this session
P/E in the 7th percentile of its own 3-year range · ROCE 35.8% (up 32.8pt over 5y) · -40.6% off its 52-week high
Composite 82.0 P/E 18.03 ROCE 35.8% Piotroski 4/8
new call this session
P/E in the 39th percentile of its own 3-year range
Composite 81.0 P/E 24.13 ROCE 69.2% Piotroski 4/9
new call this session
P/E in the 1th percentile of its own 3-year range · ROCE 90.7% (up 39.7pt over 5y) · -28.9% off its 52-week high
Composite 79.1 P/E 36.6 ROCE 90.7% Piotroski 6/8
new call this session
P/E in the 41th percentile of its own 3-year range
Composite 77.4 P/E 14.48 ROCE 26.2% Piotroski 6/9

How We Evaluate

MetricWhy it is in the frameworkSource
Return on capital, level and trendDurable high ROCE predicts future returns; the trend separates a moat from a good year Novy-Marx 2013 JFE
Gross profitability (GP/assets)As predictive as book-to-market, and less prone to the value trap Novy-Marx 2013 JFE
Piotroski F-scoreA nine-signal accounting checklist that separates real improvers from statistically cheap traps Piotroski 2000 JAR
Cash-flow-to-net-profitAccrual-heavy profit reverts; cash-backed profit persists Sloan 1996 TAR
P/E versus the stock's own historyCheap relative to itself, not to a peer set that may be expensive as a whole Basu 1977 JF
Book-to-marketThe value premium, in its original form Fama–French 1992 JF
EV/EBITDACapital-structure-neutral, so it compares a leveraged firm to an unleveraged one Practitioner standard
Altman Z and interest coverageDistressed firms have delivered lower, not higher, returns — screen them out rather than chase them Altman 1968 JF; Campbell/Hilscher/Szilagyi 2008 JF
52-week-high proximity, 200-DMANearness to the high has predicted continuation — but momentum crashes, so never alone George & Hwang 2004 JF; Daniel & Moskowitz 2016 JFE
Promoter pledgePledged promoter holding is a governance red flag ahead of a forced sale Not currently available from either source — no penalty is applied

Full derivation in METHODOLOGY.md.